WallStSmart
ABBV

AbbVie Inc

NYSE: ABBV · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$211.32
+3.64% today

Updated 2026-04-30

Market cap
$360.63B
P/E ratio
99.95
P/S ratio
5.90x
EPS (TTM)
$2.04
Dividend yield
52W range
$171 – $239
Volume
7.0M

AbbVie Inc (ABBV) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20092010201120122013201420152016201720182019202020212022202320242025
Total assets$21.13B$19.52B$27.01B$29.20B$27.51B$53.05B$66.10B$70.79B$59.35B$89.11B$150.56B$146.53B$138.81B$134.71B$135.16B$133.96B
Cash & equivalents$9.64M$27.00M$5.90B$9.60B$8.35B$8.40B$5.10B$9.30B$7.29B$39.92B$8.45B$9.75B$9.20B$12.81B$5.52B$5.23B
Current assets$8.22B$7.35B$15.35B$17.85B$16.08B$16.31B$16.19B$21.22B$16.95B$49.52B$24.17B$27.93B$28.46B$33.00B$25.58B$29.06B
Total liabilities$5.43B$7.59B$23.64B$24.71B$25.77B$49.10B$61.46B$65.69B$67.80B$97.29B$137.47B$131.09B$121.52B$124.31B$131.80B$137.19B
Current liabilities$3.76B$5.90B$6.78B$6.88B$11.39B$10.89B$9.78B$16.64B$17.24B$15.59B$28.66B$35.19B$29.54B$37.84B$38.75B$43.29B
Long-term debt$37.00M$14.63B$14.29B$10.56B$29.24B$36.44B$30.95B$35.00B$62.98B$77.55B$64.19B$59.13B$52.19B$60.34B$58.94B
Shareholder equity$15.70B$11.93B$3.36B$4.49B$1.74B$3.94B$4.64B$5.10B$-8.45B$-8.17B$13.08B$15.41B$17.25B$10.36B$3.33B$-3.27B
Retained earnings$1.57B$535.00M$2.25B$4.38B$5.46B$3.37B$4.72B$1.05B$3.13B$4.78B$-1.00B$-7.90B$-15.49B
Accounts receivable$3.37B$3.82B$4.30B$4.80B$3.73B$4.73B$4.76B$5.09B$5.38B$5.43B$8.82B$9.98B$11.25B$11.15B$10.92B$12.59B
Inventory$836.27M$872.00M$1.09B$1.15B$1.12B$1.72B$1.44B$1.60B$1.60B$1.81B$3.31B$3.13B$3.58B$4.10B$4.18B$4.95B
Goodwill$6.20B$6.10B$6.13B$6.28B$5.86B$13.17B$15.42B$15.79B$15.66B$15.60B$33.12B$32.38B$32.16B$32.29B$34.96B$35.64B